Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Pembrolizumab

Hypothyroidism: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kaur L, et al. PEMBROLIZUMAB INDUCED HYPOTHYROIDISM IN PATIENT WITH METASTATIC UTERINE SEROUS CARCINOMA MANIFESTING AS MYXEDEMA CRISIS. Journal of General Internal Medicine 38 (Suppl. 2): S616, Jul 2023. Available from: URL: http://doi.org/10.1007/s11606-023-08226-z [abstract] Kaur L, et al. PEMBROLIZUMAB INDUCED HYPOTHYROIDISM IN PATIENT WITH METASTATIC UTERINE SEROUS CARCINOMA MANIFESTING AS MYXEDEMA CRISIS. Journal of General Internal Medicine 38 (Suppl. 2): S616, Jul 2023. Available from: URL: http://​doi.​org/​10.​1007/​s11606-023-08226-z [abstract]
Metadaten
Titel
Pembrolizumab
Hypothyroidism: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44773-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Iodine

Case report

Rifampicin

Case report

Trastuzumab

Case report

Minocycline

Case report

Rifaximin